Genetic effects of dimethyl sulfate, diethyl sulfate, and related compounds

Mutation Research
|January 1, 1980
PubMed

Insights

Dimethyl sulfate (DMS) and diethyl sulfate (DES) are potent mutagens and carcinogens. These alkylating agents induce genetic alterations through various mechanisms, primarily base-pair substitutions.

Area of Science:

  • Chemical Mutagenesis
  • Genotoxicology
  • Molecular Biology

Background:

  • Dimethyl sulfate (DMS) and diethyl sulfate (DES) are monofunctional alkylating agents.
  • These agents are known to induce mutations, chromosomal aberrations, and exhibit carcinogenicity in animal models.
  • DMS acts as an SN2 agent, primarily alkylating nitrogen sites in nucleic acids.

Purpose of the Study:

  • To review and summarize the mutagenic and genetic effects of DMS and DES.
  • To elucidate the mechanisms of mutagenesis induced by these alkylating agents.
  • To compare the genetic activities of DMS and DES with related compounds like MMS and EMS.

Main Methods:

  • Review of existing mutagenesis studies involving DMS and DES.
  • Analysis of data on genetic alterations, including mutations and chromosomal aberrations.
  • Comparison of alkylating activity and genetic effects across different organisms and experimental systems.

Main Results:

  • Both DMS and DES are mutagenic across various test systems.
  • DMS-induced mutagenicity is often linked to indirect, repair-dependent processes.
  • DES can induce SN1 and SN2 alkylations, potentially alkylating oxygen sites like guanine's O6 position, contributing to mispairing.
  • The primary mutagenic effect appears to be base-pair substitutions, with some evidence for G:C to A:T transitions and deletion-type frameshift mutations.

Conclusions:

  • DMS and DES are significant genotoxic agents with mutagenic and clastogenic properties.
  • Similarities in genetic effects exist between DMS and MMS, and between DES and EMS.
  • The mechanisms of mutagenesis involve both direct DNA alkylation and indirect, repair-mediated pathways, with base-pair substitutions being a major outcome.

Related Concept Videos

Effects of Chemicals: Overview01:27

Effects of Chemicals: Overview

Drugs, encompassing various chemical compounds from natural sources, lab synthesis, or genetic engineering, elicit different biological responses in living organisms. Some of these responses are desirable or therapeutic, while others are undesirable. The primary goal of administering a drug is to achieve a therapeutic effect, that is, to address a specific disease or health condition. Any concurrent effects outside of this therapeutic outcome are considered undesirable. These undesirable...
Types of Toxins01:36

Types of Toxins

Humans continually engage with an environment rich in potentially harmful chemicals. These are introduced to our bodies through inhalation, ingestion, or skin contact. These chemicals exist in various forms, such as air and environmental pollutants, agricultural chemicals, organic solvents, and heavy metals.
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
Toxic Reactions: Overview01:26

Toxic Reactions: Overview

When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Phase II Reactions: Methylation Reactions01:17

Phase II Reactions: Methylation Reactions

Methylation is a phase II biotransformation process involving the attachment of a methyl group to a substrate. Enzymes known as methyltransferases orchestrate this reaction.
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...